BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25719894)

  • 1. Transcriptional profile of muscle following acute induction of symptoms in a mouse model of Kennedy's disease/spinobulbar muscular atrophy.
    Halievski K; Mo K; Westwood JT; Monks DA
    PLoS One; 2015; 10(2):e0118120. PubMed ID: 25719894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy.
    Mo K; Razak Z; Rao P; Yu Z; Adachi H; Katsuno M; Sobue G; Lieberman AP; Westwood JT; Monks DA
    PLoS One; 2010 Sep; 5(9):e12922. PubMed ID: 20886071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy.
    Ramzan F; McPhail M; Rao P; Mo K; Halievski K; Swift-Gallant A; Mendoza-Viveros L; Cheng HY; Monks DA
    J Neurosci; 2015 Apr; 35(16):6444-51. PubMed ID: 25904795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
    Baniahmad A
    J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease.
    Gromova A; Cha B; Robinson EM; Strickland LM; Nguyen N; ElMallah MK; Cortes CJ; La Spada AR
    Acta Neuropathol Commun; 2023 Jun; 11(1):90. PubMed ID: 37269008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Gozes I
    J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
    Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
    Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Cell-Autonomous Regulation of Retrograde Motoneuronal Axonal Transport in an SBMA Mouse Model.
    Halievski K; Kemp MQ; Breedlove SM; Miller KE; Jordan CL
    eNeuro; 2016; 3(4):. PubMed ID: 27517091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New routes to therapy for spinal and bulbar muscular atrophy.
    Rocchi A; Pennuto M
    J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
    Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
    Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
    Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
    Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.
    Xu Y; Halievski K; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
    Hum Mol Genet; 2018 Jul; 27(14):2425-2442. PubMed ID: 29897452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.
    Johansen JA; Yu Z; Mo K; Monks DA; Lieberman AP; Breedlove SM; Jordan CL
    Neurobiol Dis; 2009 Apr; 34(1):113-20. PubMed ID: 19211034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy.
    Jokela ME; Udd B
    J Mol Neurosci; 2016 Mar; 58(3):330-4. PubMed ID: 26572533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy.
    Johansen JA; Troxell-Smith SM; Yu Z; Mo K; Monks DA; Lieberman AP; Breedlove SM; Jordan CL
    Neurodegener Dis; 2011; 8(1-2):25-34. PubMed ID: 20689246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations and AR gene mutations in Kennedy's disease.
    Liu X; Zhu M; Li X; Tang J
    Funct Integr Genomics; 2019 May; 19(3):533-539. PubMed ID: 30612224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA.
    Halievski K; Henley CL; Domino L; Poort JE; Fu M; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
    Exp Neurol; 2015 Jul; 269():224-32. PubMed ID: 25929689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.
    Querin G; SorarĂ¹ G; Pradat PF
    Rev Neurol (Paris); 2017 May; 173(5):326-337. PubMed ID: 28473226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.